一个不同的AML亚组类似于APL免疫表型与DIC相关
Pan Li1, Li Liu1, Fuling Zhou2
1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
BMC cancer
|December 25, 2024
概括
患有CD34阴性,HLA-DR阴性免疫表型的急性髓性白血病 (AML) 患者面临更高的传播血管内凝血 (DIC) 风险和较差的存活率,这表明AML是一个独特的亚组. 这一发现影响了AML风险分层和治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫型定型 免疫型定型
背景情况:
- 急性髓性白血病 (AML) 的复杂性越来越多地通过不同的子组来理解.
- 在急性肌肉细胞白血病 (APL) 中识别出一种类似APL的免疫类型 (CD34阴性,HLA-DR阴性).
- 这项研究调查了AML的临床,分子和预后差异,包括和没有这种APL类型的表型.
研究的目的:
- 为了比较新的非M3型AML患者的临床,免疫类型和分子特征,包括CD34阴性,HLA-DR阴性表型的和没有CD34阴性,HLA-DR阴性表型的患者.
- 评估这种免疫类型在AML中的预后意义.
主要方法:
- 对191名新的非M3型AML患者的回顾性分析.
- 鉴定了32名具有CD34阴性,HLA-DR阴性表型的患者 (实验组).
- 与对照组的临床 (血液计数,DIC得分,OS),免疫类型和分子数据的比较.
主要成果:
- 患有CD34阴性,HLA-DR阴性表型的患者表现出明显更高的传播性血管内凝血 (DIC) 风险.
- 这个子组表现出较低的CD预后不良的标志物表达,增加了NPM1突变,以及更高的WT1基因表达.
- 与预期相反,具有这种表型的有利风险组的患者的整体存活期 (OS) 显着较短.
结论:
- CD34阴性,HLA-DR阴性免疫表型定义了一个独特的AML亚组,具有独特的临床和分子特征.
- 这个子组有DIC的倾向,这会影响预后.
- 研究结果表明,这种表型对于风险分层至关重要,并可能指导针对性AML治疗.
关键词:
在 NPM1 中,在AML,AML就是AML.在CD34−HLA-DR−表型中.DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC DIC免疫型是一种免疫型.更多相关视频
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.4K
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.6K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
01:21Lineage Commitment
2.9K
Commitment is the process whereby stem cells:
2.9K
01:27Disorders of Leukocytes
693
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
693
01:24Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638